Home  >  News
Msc_Apr23 .
you can get e-magazine links on WhatsApp. Click here
  US FDA accepts for priority review new BLA for Merck’s activin signalling inhibitor, sotatercept to treat adults with PAH,   September 29, 2023
  Motus GI seeks US FDA special 510(K) clearance for its Pure-Vu Gen 4 Gastro and Colon,   September 28, 2023
  Superceuticals unveils biochemical and biophysical analyzer 'SC-AN 2.4' as part of healthcare innovation,   September 28, 2023
  8 out of 10 women reveal PCOS affects their self-esteem & body image: Study,   September 28, 2023
  Cue Biopharma completes patient enrollment in phase 1b study of CUE-101 in combo with Keytruda in first line refractory/metastatic HPV+ head and neck cancer,   September 28, 2023
  Apollo Hospitals celebrates its leadership as the largest cardiac centre of excellence,   September 28, 2023
  Revvity launches pin-point base editing technology to accelerate development of new cell therapies,   September 28, 2023
  Govt steps up efforts to strengthen cancer care, makes 50% onco drugs cheaper: Dr Mansukh Mandaviya,   September 28, 2023
  Indian mycobacterium tuberculosis tests market to grow at 4% CAGR through 2033: GlobalData,   September 28, 2023
  Exo introduces a new age of ultrasound with Exo Iris,   September 28, 2023
  Medicover Hospitals launches nationwide CPR training campaign with the aim to train over 30,000 people,   September 28, 2023
  HCG Cancer Centre Jaipur unveils North India’s first-of-its-kind Elekta Harmony Pro Radiotherapy Platform,   September 28, 2023
  Ginkgo Bioworks, Pfizer collaborate to discover RNA-based drug candidates,   September 28, 2023
  Lupin’s digital asthma educator platform, Joint Airways Initiative surpasses 10,000 patients,   September 28, 2023
  Saluda Medical receives US FDA approval for Evoke System MRI labelling,   September 28, 2023
  US FDA grants Fast Track designation to Ideaya Biosciences’ IDE161 to treat pretreated, advanced or metastatic HR+, Her2-, BRCA1/2 mutant breast cancer,   September 28, 2023
  Ionis Pharma phase 3 Balance study of olezarsen in people with familial chylomicronemia syndrome meets primary efficacy endpoint,   September 28, 2023
  Doceree raises US$ 35 mn in Series B funding, led by Creaegis with participation from Eight Roads Ventures & F-Prime Capital,   September 28, 2023
  Ono inks collaboration with Adimab to discover novel antibody drugs in oncology field,   September 28, 2023
  UKHSA announces new UK-based vaccine deal to boost pandemic preparedness against influenza,   September 28, 2023

Pharma live expo
Copyright © 2023 Saffron Media Pvt. Ltd |